Jonathan W. Ayers - 18 May 2023 Form 4 Insider Report for IDEXX LABORATORIES INC /DE (IDXX)

Reporting relationship: Director
Issuer ticker: IDXX
Reported as of: 18 May 2023
Net transaction value: -$8,214,971
SEC form: 4
Accepted by SEC: 22 May 2023, 17:00:32 UTC
Prior SEC filing: 19 May 2023
Next SEC filing: 14 Aug 2023
Source filing: View source filing
Reporting owner signature: /s/ Lily J. Lu, Attorney-in-Fact for Jonathan W. Ayers

Key filing fact

Jonathan W. Ayers filed Form 4 for IDEXX LABORATORIES INC /DE (IDXX) on 22 May 2023.

Key facts

This page summarizes Jonathan W. Ayers's Form 4 filing for IDEXX LABORATORIES INC /DE (IDXX).
20 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 22 May 2023, 17:00.

Change

Previous filing in this sequence was filed on 19 May 2023.
Current net transaction value: -$8,214,971.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IDXX transaction

Common Stock

Options Exercise

Transaction value: $795,400
Shares: +10,000
Change %: +7.3%
Price: $79.54^*
Shares after: 147,039
Date: 18 May 2023
Ownership: Direct

IDXX transaction

Common Stock

Sale

Transaction value: $486,482
Shares: -1,000
Change %: -0.68%
Price: $486.48
Shares after: 146,039
Date: 18 May 2023
Ownership: Direct
Footnotes: F1

IDXX transaction

Common Stock

Sale

Transaction value: $1,343,011
Shares: -2,753
Change %: -1.9%
Price: $487.84
Shares after: 143,286
Date: 18 May 2023
Ownership: Direct
Footnotes: F2

IDXX transaction

Common Stock

Sale

Transaction value: $494,498
Shares: -1,012
Change %: -0.71%
Price: $488.63
Shares after: 142,274
Date: 18 May 2023
Ownership: Direct
Footnotes: F3

IDXX transaction

Common Stock

Sale

Transaction value: $1,097,926
Shares: -2,242
Change %: -1.6%
Price: $489.71
Shares after: 140,032
Date: 18 May 2023
Ownership: Direct
Footnotes: F4

IDXX transaction

Common Stock

Sale

Transaction value: $831,858
Shares: -1,695
Change %: -1.2%
Price: $490.77
Shares after: 138,337
Date: 18 May 2023
Ownership: Direct
Footnotes: F5

IDXX transaction

Common Stock

Sale

Transaction value: $638,494
Shares: -1,298
Change %: -0.94%
Price: $491.91
Shares after: 137,039
Date: 18 May 2023
Ownership: Direct
Footnotes: F6

IDXX transaction

Common Stock

Options Exercise

Transaction value: $795,400
Shares: +10,000
Change %: +7.3%
Price: $79.54^*
Shares after: 147,039
Date: 19 May 2023
Ownership: Direct

IDXX transaction

Common Stock

Sale

Transaction value: $554,116
Shares: -1,138
Change %: -0.77%
Price: $486.92
Shares after: 145,901
Date: 19 May 2023
Ownership: Direct
Footnotes: F7

IDXX transaction

Common Stock

Sale

Transaction value: $1,099,539
Shares: -2,254
Change %: -1.5%
Price: $487.82
Shares after: 143,647
Date: 19 May 2023
Ownership: Direct
Footnotes: F8

IDXX transaction

Common Stock

Sale

Transaction value: $639,317
Shares: -1,308
Change %: -0.91%
Price: $488.77
Shares after: 142,339
Date: 19 May 2023
Ownership: Direct
Footnotes: F9

IDXX transaction

Common Stock

Sale

Transaction value: $147,008
Shares: -300
Change %: -0.21%
Price: $490.03
Shares after: 142,039
Date: 19 May 2023
Ownership: Direct
Footnotes: F10

IDXX transaction

Common Stock

Sale

Transaction value: $196,636
Shares: -400
Change %: -0.28%
Price: $491.59
Shares after: 141,639
Date: 19 May 2023
Ownership: Direct
Footnotes: F11

IDXX transaction

Common Stock

Sale

Transaction value: $702,757
Shares: -1,426
Change %: -1%
Price: $492.82
Shares after: 140,213
Date: 19 May 2023
Ownership: Direct
Footnotes: F12

IDXX transaction

Common Stock

Sale

Transaction value: $607,465
Shares: -1,229
Change %: -0.88%
Price: $494.28
Shares after: 138,984
Date: 19 May 2023
Ownership: Direct
Footnotes: F13

IDXX transaction

Common Stock

Sale

Transaction value: $439,398
Shares: -886
Change %: -0.64%
Price: $495.94
Shares after: 138,098
Date: 19 May 2023
Ownership: Direct
Footnotes: F14

IDXX transaction

Common Stock

Sale

Transaction value: $377,721
Shares: -759
Change %: -0.55%
Price: $497.66
Shares after: 137,339
Date: 19 May 2023
Ownership: Direct
Footnotes: F15

IDXX transaction

Common Stock

Sale

Transaction value: $149,544
Shares: -300
Change %: -0.22%
Price: $498.48
Shares after: 137,039
Date: 19 May 2023
Ownership: Direct
Footnotes: F16

IDXX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 450,000
Date: 18 May 2023
Ownership: by Jonathan W. Ayers 2022 GRAT
Footnotes: F17

IDXX holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 10,000
Date: 18 May 2023
Ownership: by Ayers Family Trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IDXX transaction Derivative

Non-Qualified Stock Option (right-to-buy)

Options Exercise

Transaction value
Shares: -10,000
Change %: -8.7%
Price
Shares after: 105,540
Date: 18 May 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price: $79.54
Footnotes: F18, F19

IDXX transaction Derivative

Non-Qualified Stock Option (right-to-buy)

Options Exercise

Transaction value
Shares: -10,000
Change %: -9.5%
Price
Shares after: 95,540
Date: 19 May 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price: $79.54
Footnotes: F18, F19

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 19 footnotes

Footnote F1

Represents the weighted average price of the shares sold ranging from a low of $486.08 to a high of $487.03 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Footnote F2

Represents the weighted average price of the shares sold ranging from a low of $487.19 to a high of $488.19 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Footnote F3

Represents the weighted average price of the shares sold ranging from a low of $488.21 to a high of $489.02 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Footnote F4

Represents the weighted average price of the shares sold ranging from a low of $489.32 to a high of $490.32 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Footnote F5

Represents the weighted average price of the shares sold ranging from a low of $490.375 to a high of $491.30 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Footnote F6

Represents the weighted average price of the shares sold ranging from a low of $491.54 to a high of $492.345 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Footnote F7

Represents the weighted average price of the shares sold ranging from a low of $486.29 to a high of $487.27 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Footnote F8

Represents the weighted average price of the shares sold ranging from a low of $487.34 to a high of $488.32 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Footnote F9

Represents the weighted average price of the shares sold ranging from a low of $488.41 to a high of $489.35 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Footnote F10

Represents the weighted average price of the shares sold ranging from a low of $489.865 to a high of $490.11 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Footnote F11

Represents the weighted average price of the shares sold ranging from a low of $491.36 to a high of $491.74 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Footnote F12

Represents the weighted average price of the shares sold ranging from a low of $492.38 to a high of $493.31 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Footnote F13

Represents the weighted average price of the shares sold ranging from a low of $493.37 to a high of $494.53 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Footnote F14

Represents the weighted average price of the shares sold ranging from a low of $495.53 to a high of $496.45 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Footnote F15

Represents the weighted average price of the shares sold ranging from a low of $497.00 to a high of $497.99 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Footnote F16

Represents the weighted average price of the shares sold ranging from a low of $498.47 to a high of $498.50 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.

Footnote F17

The reporting person is the grantor and trustee of the Jonathan W. Ayers 2022 GRAT (the "GRAT"). The GRAT is irrevocable, and the reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.

Footnote F18

Grant of option to buy 74,316 shares of IDEXX Laboratories, Inc. common stock that became exercisable in five equal annual installments beginning on February 14, 2016 without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.

Footnote F19

Not applicable.